Compositions comprising 1-oxo- or thiohydrocarbyl substituted az

Details Compositions comprising 1-oxo- or thiohydrocarbyl substituted az Compositions comprising 1-oxo- or thiohydrocarbyl substituted az

1987-09-30

1990-04-24

Davis, Curtis R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 29, 514 50, 514179, 514183, 514212, 514269, 514273, 514315, 514316, 514327, 514328, 514330, 514514, 514946, 514947, A01N 3119, A01N 3140, A01N 4336

Patent

active

049201018

ABSTRACT:
This invention provides compositions comprising a physiologically-active agent and a compound represented by the general formula ##STR1## wherein X may represent sulfur, oxygen or 2 hydrogen radicals; Y may represent --CH.sub.2 --, --NH-- or oxygen; n and m are integers of from 1 to 3; p is an integer of from 3 to 17; q is 2, 4, 6 or 8; wherein p.gtoreq.9; and R' is selected from the group consisting of H, a lower alkyl group having from 1 to 4 carbon atoms, phenyl, lower alkyl or halogen substituted phenyl, acetamido, halogen, piperidinyl, lower alkyl or halogen substituted piperidinyl, carbalkoxy, carboxamide, and alkanoyl. These compositions are useful in topical or transdermal applications of the physiologically-active agent.

REFERENCES:
patent: 3051616 (1962-08-01), Drapal
patent: 3085931 (1963-04-01), Darlington
patent: 3157641 (1964-02-01), Walles et al.
patent: 3306910 (1967-02-01), Louthan
patent: 3306911 (1967-02-01), Doss
patent: 3332938 (1967-07-01), Mayhew et al.
patent: 3341517 (1967-09-01), Buechel et al.
patent: 3342673 (1967-09-01), Kaufman et al.
patent: 3551544 (1970-12-01), Herschler
patent: 3598122 (1971-08-01), Zaffaroni
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3678156 (1972-07-01), MacMillan et al.
patent: 3731683 (1973-05-01), Zaffaroni
patent: 3742951 (1973-05-01), Zaffaroni
patent: 3814097 (1974-06-01), Ganderton et al.
patent: 3823152 (1974-07-01), Morimoto et al.
patent: 3865814 (1975-02-01), Lussi et al.
patent: 3891757 (1975-06-01), Higuchi
patent: 3921636 (1975-11-01), Zaffaroni
patent: 3954966 (1976-05-01), Lim et al.
patent: 3960922 (1976-06-01), Baker et al.
patent: 3966806 (1976-06-01), Baker et al.
patent: 3972995 (1976-08-01), Tsuk et al.
patent: 3989815 (1976-11-01), Rajadkyaksha
patent: 3989816 (1976-11-01), Rajadhyaksha
patent: 3991203 (1976-11-01), Rajadkyaksha
patent: 3993072 (1976-11-01), Zaffaroni
patent: 3993073 (1976-11-01), Zaffaroni
patent: 3996934 (1976-12-01), Zaffaroni
patent: 4021224 (1977-05-01), Pallos et al.
patent: 4031894 (1977-06-01), Urfahart
patent: 4060084 (1977-11-01), Chandrasek et al.
patent: 4069307 (1978-01-01), Higuchi et al.
patent: 4077407 (1978-03-01), Theeumes
patent: 4118500 (1978-10-01), Pritzlaff et al.
patent: 4122170 (1978-10-01), Rajadkyaksha
patent: 4201211 (1980-05-01), Chandrasek et al.
patent: 4230105 (1981-08-01), Hussain et al.
patent: 4264594 (1981-08-01), McGovern et al.
patent: 4284648 (1981-08-01), Hussain et al.
patent: 4292299 (1981-09-01), Suziki
patent: 4292303 (1981-09-01), Keith et al.
patent: 4310525 (1982-01-01), Nelson
patent: 4311481 (1982-01-01), Nelson
patent: 4316893 (1982-02-01), Rajadhyaksha
patent: 4364952 (1982-12-01), Materne
patent: 4405616 (1983-09-01), Rajadhyaksha
patent: 4415563 (1983-11-01), Rajadhyaksha
patent: 4423040 (1983-12-01), Rajadkyaksha
patent: 4424210 (1984-01-01), Rajadhyaksha
patent: 4440777 (1984-04-01), Zupan
patent: 4444762 (1984-04-01), Rajadhyaksha
patent: 4525199 (1985-06-01), Rajadkyaksha
patent: 4537776 (1985-08-01), Cooper
patent: 4552872 (1985-11-01), Cooper
patent: 4557934 (1985-12-01), Cooper
patent: 4562075 (1985-12-01), Rajadhyaksha
patent: 4565823 (1986-01-01), Ohata et al.
patent: 4605670 (1986-08-01), Saito
patent: 4620949 (1986-11-01), Lin
patent: 4621143 (1986-11-01), McGovern et al.
patent: 4626539 (1986-12-01), Aungst et al.
Bennett, S. L., et al., "Optimization of Bioavailability of Topical Steroids: Non-Occluded Penetration Enhancers Under Thermodynamic Control," J. Pharm. Pharmacol., 37(5): 298-304, 1985.
Goldman, L., et al., "Preliminary Investigative Studies with DDT in Dermatologic and Plastic Surgery", Laser Surg. Med., 5(5): 453-456, 1985.
Chow, DS-L, et al., "Concentration-Dependent Enhancement of 1-Dodecylazacyloheptan-2-one on the Percutaneous Penetration Kinetics of Triamcinolone Acetonide", J. Pharm. Sci., 73(12):1794-1799, 1984.
DeClercq, E., "Topical Treatment of Cutaneous Herpes Simplex Virus Infection in Hairless Mice with (E)-5-(2-Bromovinyl)-2'-Dioxyurdine and Related Compounds", Antimicrob Agents Chemother, 26(2): 155-159, 1984.
Goodman, M., et al., Differential Scanning Colorimetry (DSC) of Human Stratum Corneum: Effect of Azone.Presentation at the British Pharmaceutical Conference Leeds, 1985.
Hadgraft, J., et al., "Facilitated Transport of Sodium Salicylate Across an Artificial Lipid Membrane by Azone", J. Pharm. Pharmacol., 37(10): 725-727, 1985.
Higuchi, W. I., "Macro--and Micro-Physical Chemical Considerations in Understanding Drug Transport in the Stratum Corneum", Second Int'l Symp. Recent Advances in Drug Delivery Systems, Salt Lake City, Utah, 1985.
Higuchi, W. I., et al., "Topical Delivery of Antiviral Agents: In Vivo/In Vitro Correlations", Proc. Int. Symp., pp. 1-17, 1984.
Hoelgaard, A., "Dermal Drug Delivery--Improvement by Choice of Vehicle or Drug Derivative", 2nd Int'l Symp. Recent Adv. Drug Delivery Systems, 1985.
Chemical Abstracts: 69:86313p, 82:39533u, 82:93905e, 83:1758d, 83:91780g, 102:183860x, 104:174644u.
Liang, W. Q., et al., "Affect of Azone on Local Pharmacokinetics of Para-Aminobenzoic Acid in Skin", 11th Int'l Symp. Controlled Release Bioactive Mat., 1984.
Maibach, H. I., et al., "Phototoxicity (Photoirritation) of Topical and Systemic Agents", Advance in Modern Toxicology, 4:211-223, 1.
Marzulli, F. N., et al., "Contact Allergy: Predictive Testing in Humans, Advances" in Modern Toxicology, 4:253-372, 1977.
McCullogh, J. L., et al., "Regulation of Epidermal Prolifieration in Mouse Epidermis by Combination of Difluoromethyl Ornithine (DFMO) and Methylglyoxal Bis(guancylhydrazone) (MGBG)", J. Invest. Dermatol., 85(6): 518-521, 1985.
McCullogh, J. L., et al., "Development of a Topical Hematoporphysin Derivative Formulation: Characterization of Photosensitizing Effects. In Vivo.," J. Invest. Dermatol, 81(6): 528-532, 1983.
Ohshima, T., et al., "Enhancing Effect on Absorption Promoters on Percutaneous Absorption of a Model Dye (6-Carboxyfluorescein) as Poorly Absorbable Drugs. II. Study on the Absorption Promoting Effect of Azone", J. Pharm. Dyn., 8:900-905, 1985.
Ryatt, J. K., "Pharmacodynamic Measurement of Percutaneous Penetration Enhancement In Vivo", J. Pharm. Sci., 75:(4) 374-377, 1986.
Stoughton, R. B., "Azone as a Promoter of Percutaneous Absorption", (1983), Acta Pharm., 20(1):62.
Shannon, W. M., et al., "Influence of 1-Dodecylazacydoheptane-2-one (Azone) on the Topical Therapy of Cutaneous Herpes Simples Virus Type 1 Infection in Hairless Mice with 2',3'-D-Arabinofuranosyladenine", J. Pharm. Sci., 74(11):1157-1161, 1985.
Spruance, S. I., et al., "Effect of Azone and Propylene Glycol on Penetration of Trifluorothymidine Through Skin and Efficacy of Different Topical Formulations Against Cutaneous Herpes Simplex Virus Infects in Guinea Pigs", Antimicrob Agent Chermother, 25(5):819-823, 1984.
Stoughton, R. B., et al., "Azone.RTM.: A New Non-Toxic Enhancer of Cutaneous Penetration", Drug Dev. Ind. Pharm., 9(4):725-744, 1983.
Stoughton, R. B., "Azone Enhances Percutaneous Penetration", IN: Psoriasis Proceedings of the Third Int'l Sump., 397-8, 1982.
Stoughton, R. B., "Enhanced Percutaneous Penetration with 1-Dodecylazacycloheptan-2-one", Archives of Derm., 118:474-477, 1982.
Sugibayashi, K., et al., "Effect of the Absorption Enhancer, Azone, on the Transport of 4-Fluorouracil Across Hairless Rat Skin", J. Pharm. Pharm., 37(8):578-580, 1985.
Toutitou, E., et al., "Effect of Propylene Glycol, Azone and N-Decylmethyl Suphoxide on Skin Permeation Kinetics of 5-Fluorouracil," Int. J. Pharm., 1(27): 89-98, 1985.
Wooton, P. K., et al., "Vehicle Effect on Topical Drug Delivery. III. Effect of Azone on the Cutaneous Permeation of Metronidazole and Propylene Glycol", Int. J. Pharm., 1(24):19-26, 1985.
Rajadkyaksha, V., et al., "Transdermal Delivery of ISDN from Hercon Patches Containing Azone", Proceed Intern. Symp. Control Rel. Biact. Mater., 12, (222-323), 1985.
Zoler, M. L., "Skin Penetration of Antiherpes Drugs Can Be Enhanced by Azone", Dermatology Times, 5(2), 1984.
Hadgraft, J., "Percutaneous Absorption", Cos & Toiletries 100, 32-38, 1985.
Mehr, A. Z., "Evaluation of Commerical an

Affiliated with

Also associated with

Rating

Compositions comprising 1-oxo- or thiohydrocarbyl substituted az does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions comprising 1-oxo- or thiohydrocarbyl substituted az, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions comprising 1-oxo- or thiohydrocarbyl substituted az will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-34789